Purexa Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Purexa General Information

Description

Developer of disposable membrane chromatography columns designed to purify biologics for research and early-stage drug trials. The company's columns are used for the downstream purification of a range of therapeutic agents that include monoclonal antibodies, recombinant and fusion proteins, enabling researchers to improve the speed of early-stage development to get biologics to market where they are needed, to serve growing population of patients with long-term, chronic conditions such as cancers, cardiovascular diseases and autoimmune disorders.

Contact Information

Website
www.purexa.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 215 Innovation Drive
  • Suite D
  • Greenville, SC 29607
  • United States
+1 (864)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 215 Innovation Drive
  • Suite D
  • Greenville, SC 29607
  • United States
+1 (864)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Purexa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 29-Apr-2025 Completed Generating Revenue
8. Merger/Acquisition 13-Jun-2022 Completed Generating Revenue
7. Grant 01-Aug-2021 Completed Generating Revenue
6. Grant 01-Aug-2021 Completed Generating Revenue
5. Grant 30-Aug-2018 Completed Generating Revenue
4. Grant 01-Jan-2017 Completed Generating Revenue
3. Grant 01-Jan-2016 Completed Generating Revenue
2. Accelerator/Incubator 16-Apr-2015 Completed Startup
1. Grant $80K Completed Startup
To view Purexa’s complete valuation and funding history, request access »

Purexa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of disposable membrane chromatography columns designed to purify biologics for research and early-stage drug t
Drug Discovery
Greenville, SC
11 As of 2025

Paris, France
 

Foster City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Purexa Competitors (16)

One of Purexa’s 16 competitors is Cellectis, a Formerly VC-backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellectis Formerly VC-backed Paris, France
Gilead Formerly VC-backed Foster City, CA
Cell Signaling Technology Corporation Danvers, MA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 16 competitors. Get the full list »

Purexa Patents

Purexa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230010637-A1 Epoxide-activated substrates and hydrophobic interaction chromatography made therefrom for polynucleotide purification Pending 12-Jul-2021
WO-2022104197-A1 Methods of oligonucleotide-based affinity chromatography Inactive 13-Nov-2020
JP-2022512344-A Affinity film and manufacturing method Active 12-Dec-2018
WO-2020123714-A1 Affinity membrane and method of preparation Inactive 12-Dec-2018 B01J20/3274

Purexa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Purexa Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clemson University Foundation Limited Partner
Groupe Michelin Corporation
National Institute of General Medical Sciences Government
National Institutes of Health Government
SC EPSCoR/IDeA Foundation Government
You’re viewing 5 of 10 investors. Get the full list »

Purexa FAQs

  • When was Purexa founded?

    Purexa was founded in 2013.

  • Where is Purexa headquartered?

    Purexa is headquartered in Greenville, SC.

  • What is the size of Purexa?

    Purexa has 11 total employees.

  • What industry is Purexa in?

    Purexa’s primary industry is Drug Discovery.

  • Is Purexa a private or public company?

    Purexa is a Private company.

  • What is Purexa’s current revenue?

    The current revenue for Purexa is .

  • Who are Purexa’s investors?

    Clemson University Foundation, Groupe Michelin, National Institute of General Medical Sciences, National Institutes of Health, and SC EPSCoR/IDeA Foundation are 5 of 10 investors who have invested in Purexa.

  • Who are Purexa’s competitors?

    Cellectis, Gilead, Cell Signaling Technology, Abcam, and Bristol-Myers Squibb are some of the 16 competitors of Purexa.

  • When was Purexa acquired?

    Purexa was acquired on 29-Apr-2025.

  • Who acquired Purexa?

    Purexa was acquired by Donaldson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process